3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Central Nervous System Helminthiasis: new trials by email Literature Review of Central Nervous System Helminthiasis trials Research Report on Central Nervous System Helminthiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Oxfendazole, Placebo - Neurocysticercosis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 70 | 2014-11-17 | 2020-11-02 |
| PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB [F-18]FBR - Neurocysticercosis, Healthy | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 24 | 2007-09-04 | 2018-07-05 |
| PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 [C-11]PBR28 - Neurocysticercosis, Healthy | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 18 | 2007-09-04 | 2019-12-12 |
Neurocysticercosis (3) · Taeniasis (3) · Epilepsy (2) · Neuroinflammatory Diseases (2)
Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Central Nervous System Parasitic Infections (3) · Cestode Infections (3) · Cysticercosis (3) · Helminthiasis (3) · Infections (3) · Nervous System Diseases (3) · Parasitic Diseases (3) · Brain Diseases (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
oxfendazole (1)
National Institute of Mental Health (NIMH) (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3)